Pages that link to "Q34311814"
Jump to navigation
Jump to search
The following pages link to Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer (Q34311814):
Displaying 46 items.
- Arylamine N-acetyltransferase 1: a novel drug target in cancer development (Q26829025) (← links)
- Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis (Q26996794) (← links)
- An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma (Q28076342) (← links)
- CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies (Q28392197) (← links)
- High risk factors of pancreatic carcinoma. (Q30249161) (← links)
- Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review (Q33678877) (← links)
- CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response (Q33888862) (← links)
- Risk factors for pancreatic cancer: case-control study (Q34582332) (← links)
- K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking (Q34596601) (← links)
- Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. (Q35015993) (← links)
- Lack of association of the N-acetyltransferase NAT1*10 allele with prostate cancer incidence, grade, or stage among smokers in Finland (Q35164091) (← links)
- Association between alcohol consumption and pancreatic cancer risk: a case-control study (Q35344972) (← links)
- The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk (Q35510411) (← links)
- NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl (Q35552622) (← links)
- Phenotype of the most common "slow acetylator" arylamine N-acetyltransferase 1 genetic variant (NAT1*14B) is substrate-dependent (Q35647164) (← links)
- Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3' untranslated regions (Q35657155) (← links)
- Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes (Q35688348) (← links)
- Functional analysis of arylamine N-acetyltransferase 1 (NAT1) NAT1*10 haplotypes in a complete NATb mRNA construct. (Q35730604) (← links)
- Dietary mutagen exposure and risk of pancreatic cancer (Q35842595) (← links)
- Effects of base excision repair gene polymorphisms on pancreatic cancer survival (Q35842670) (← links)
- Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk (Q35883577) (← links)
- Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses (Q35920271) (← links)
- Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1 (Q35956690) (← links)
- NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis (Q35958666) (← links)
- Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. (Q36158505) (← links)
- Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism. (Q36328678) (← links)
- Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer (Q36408201) (← links)
- Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae (Q36450003) (← links)
- Genetic susceptibility to pancreatic cancer (Q36603692) (← links)
- Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer (Q36743654) (← links)
- Past and future applications of CYP450-genetic polymorphisms for biomonitoring of environmental toxicants (Q37000474) (← links)
- Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer (Q37010354) (← links)
- Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms (Q37157901) (← links)
- Update on the pharmacogenetics of NATs: structural considerations (Q37329162) (← links)
- Pancreatic cancer patients who smoke and drink are diagnosed at younger ages (Q37329324) (← links)
- An Overview of Genetic Polymorphisms and Pancreatic Cancer Risk in Molecular Epidemiologic Studies (Q37506586) (← links)
- Epidemiology of pancreatic cancer: an overview (Q37608905) (← links)
- Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective (Q37715233) (← links)
- Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer (Q37967627) (← links)
- Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity (Q38396102) (← links)
- Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis (Q41730140) (← links)
- Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453). (Q42159015) (← links)
- Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia. (Q48161555) (← links)
- N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer. (Q54455459) (← links)
- Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1 (Q80660182) (← links)
- Dietary N-nitroso compounds and risk of pancreatic cancer: results from a large case-control study (Q93369549) (← links)